Cancer
Malignant Bladder Neoplasm
CI-CAN-00005866Explore in graph →
Top-level347 active trials10 approved drugs26 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005866Explore in graph →
Clinical trials
1,512 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04267575 | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | unknown | N/A | 20 | Jerome Canady, M.D.OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04358718 | Influence of Opioids on Circulating Tumor Cells in Radical Cystectomy | completed | N/A | 44 | RenJi HospitalOTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT03063125 |
| Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer |
| completed |
| — |
| 25 |
| University of Kansas Medical CenterOTHER |
| 1 |
| Aug 3, 2021 |
| clinicaltrials |
| NCT02252549 | An International Randomized Study to Compare SPIES Versus WLI | completed | N/A | 700 | Clinical Research Office of the Endourological SocietyOTHER | 0 | Jul 28, 2021 | clinicaltrials |
| NCT04966130 | Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder. | unknown | — | 96 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jul 19, 2021 | clinicaltrials |
| NCT04966949 | Lateral Prostate Capsule Sparing Versus Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male | unknown | N/A | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 19, 2021 | clinicaltrials |
| NCT04966962 | Establishment and Validation of an Early Diagnostic Model for Bladder Cancer Based on Serum and Urine Metabolomics | unknown | — | 180 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jul 19, 2021 | clinicaltrials |
| NCT04966975 | Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy | unknown | — | 60 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jul 19, 2021 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04958330 | Lateral Prostate Capsule Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male | unknown | — | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 12, 2021 | clinicaltrials |
| NCT04958343 | Application and Clinical Effectiveness of Pelvic Reconstruction in Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder in the Male | unknown | — | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 12, 2021 | clinicaltrials |
| NCT03327883 | Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer | completed | — | 15 | National Cancer Institute (NCI)NIH | 1 | Jul 9, 2021 | clinicaltrials |
| NCT04601766 | A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets | completed | Phase 1 | 12 | Asieris Pharmaceuticals (AUS) Pty Ltd.INDUSTRY | 1 | Jun 30, 2021 | clinicaltrials |
| NCT02340650 | High Resolution Imaging for Early and Better Detection of Bladder Cancer(HRME_Bladder) | completed | — | 37 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jun 25, 2021 | clinicaltrials |
| NCT04939194 | Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial. | unknown | Phase 3 | 200 | Mansoura UniversityOTHER | 1 | Jun 25, 2021 | clinicaltrials |
| NCT02852252 | Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry | completed | — | 291 | University of PennsylvaniaOTHER | 1 | Jun 18, 2021 | clinicaltrials |
| NCT04579133 | Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy | terminated | Phase 2 | 140 | Latin American Cooperative Oncology GroupOTHER | 1 | Jun 16, 2021 | clinicaltrials |
| NCT02298998 | Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study | completed | — | 41 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT00118040 | Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Jun 10, 2021 | clinicaltrials |
| NCT02009332 | Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer | completed | Phase 1 / Phase 2 | 21 | Aadi Bioscience, Inc.INDUSTRY | 1 | Jun 8, 2021 | clinicaltrials |
| NCT04909775 | Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer | unknown | Phase 2 | 40 | Ruijin HospitalOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT04900558 | Robotic Radical Cystectomy Outcomes | recruiting | — | 500 | University of FlorenceOTHER | 1 | May 25, 2021 | clinicaltrials |
| NCT04885309 | Efficacy and Safety of Obturator Nerve Block During Transurethral Resection on Non-muscle Invasive Intermediate and High Risk Lateral Wall Bladder Tumours | completed | N/A | 104 | Ankara Training and Research HospitalOTHER | 1 | May 13, 2021 | clinicaltrials |
| NCT04464967 | Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers | withdrawn | Phase 1 / Phase 2 | 0 | NKGen Biotech, Inc.INDUSTRY | 0 | May 12, 2021 | clinicaltrials |
| NCT04878250 | Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder(PEBBLE) | unknown | Phase 2 | 49 | Queen Mary University of LondonOTHER | 0 | May 7, 2021 | clinicaltrials |
| NCT01827943 | Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer(VESTOR) | completed | Phase 2 | 54 | Institut BergoniéOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT02647112 | Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma | completed | N/A | 1,050 | Nucleix Ltd.INDUSTRY | 4 | May 4, 2021 | clinicaltrials |
| NCT02700464 | The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma | completed | N/A | 680 | Nucleix Ltd.INDUSTRY | 2 | May 4, 2021 | clinicaltrials |
| NCT04872036 | Prognostic Biomarkers in Patients With Urothelial Carcinoma | completed | — | 66 | Hellenic Cooperative Oncology GroupOTHER | 0 | May 4, 2021 | clinicaltrials |
| NCT03257293 | A Trial of a Modified Cystoscopy Method to Reduce Pain Perception | completed | N/A | 93 | Western University, CanadaOTHER | 1 | Apr 27, 2021 | clinicaltrials |
| NCT01438112 | Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer(BOND) | terminated | Phase 2 / Phase 3 | 22 | CG Oncology, Inc.INDUSTRY | 1 | Apr 14, 2021 | clinicaltrials |
| NCT02365818 | Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure(BOND2) | completed | Phase 2 | 66 | CG Oncology, Inc.INDUSTRY | 1 | Apr 14, 2021 | clinicaltrials |
| NCT04838873 | Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center | completed | N/A | 60 | Cairo UniversityOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT02552121 | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 33 | Seagen Inc.INDUSTRY | 5 | Apr 8, 2021 | clinicaltrials |
| NCT03664869 | Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer(FB10) | unknown | Phase 3 | 300 | Turku University HospitalOTHER_GOV | 1 | Apr 1, 2021 | clinicaltrials |
| NCT00461591 | Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) | completed | Phase 3 | 802 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Mar 30, 2021 | clinicaltrials |
| NCT03063255 | Comparison of Obturator Nerve Blockade and Neuromuscular Blockade | completed | Phase 4 | 60 | University of FloridaOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT04812145 | Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma | unknown | — | 50 | Assiut UniversityOTHER | 0 | Mar 23, 2021 | clinicaltrials |
| NCT02753309 | A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer | completed | Early Phase 1 | 33 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Mar 19, 2021 | clinicaltrials |
| NCT02880176 | Steps to Eliminate Postoperative Problems(STEPP) | completed | N/A | 34 | University of PennsylvaniaOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT02800473 | Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection(CyPaM2) | completed | N/A | 10 | Institut de Cancérologie de LorraineOTHER | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04334226 | The Impact of Preoperative Urostomy Education on Patients and Families(StomABC Impact) | completed | — | 16 | University of Kansas Medical CenterOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT04768894 | Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates | completed | N/A | 109 | Saglik Bilimleri UniversitesiOTHER | 0 | Feb 26, 2021 | clinicaltrials |
| NCT02897765 | A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer | completed | Phase 1 | 34 | BioNTech US Inc.INDUSTRY | 1 | Feb 25, 2021 | clinicaltrials |
| NCT03125226 | TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer | completed | N/A | 12 | University of WashingtonOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT03824691 | hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"(ARCADIA) | unknown | Phase 2 | 122 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT00006111 | Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract | completed | Phase 2 | 53 | UNICANCEROTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT04750590 | Relationship Between Methods of Bladder Tumor Extraction and Local Recurrence Rate | unknown | N/A | 180 | I.M. Sechenov First Moscow State Medical UniversityOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT04305730 | Use of Pedometer Following Radical Cystectomy | unknown | N/A | 35 | Benaroya Research InstituteOTHER | 1 | Feb 16, 2021 | clinicaltrials |
| NCT04756284 | Evaluation of the PhageTech Virus BioResistor | unknown | — | 50 | PhageTech, Inc.INDUSTRY | 1 | Feb 16, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Aug 9, 2021source: clinicaltrials